Association between Baseline Cortisol Serum Concentrations and the Effect of Prophylactic Hydrocortisone in Extremely

Chloe Renolleau1, Artemis Toumazi2, Aurélie Bourmaud2

  • 1Neonatal Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, University Paris Diderot, Sorbone Paris Cité, Paris, France.

The Journal of Pediatrics
|December 28, 2020
PubMed

Insights

High early serum cortisol levels in extremely preterm infants may improve survival without bronchopulmonary dysplasia (BPD) in placebo groups. However, hydrocortisone treatment in infants with high cortisol levels increases risks of severe intraventricular hemorrhage and intestinal perforation.

Area of Science:

  • Neonatalogy
  • Endocrinology
  • Pediatric Critical Care

Background:

  • Extremely preterm infants often require interventions for survival and to prevent morbidities.
  • Serum cortisol levels in neonates may influence outcomes, but their role in relation to prophylactic hydrocortisone is not fully understood.
  • Establishing nomograms for early postnatal serum cortisol is crucial for understanding its impact on extremely preterm infants.

Purpose of the Study:

  • To establish nomograms for serum cortisol values within 24 hours of birth in extremely preterm infants.
  • To determine if baseline cortisol levels affect the benefit/risk ratio of prophylactic hydrocortisone for BPD-free survival.
  • To investigate the association between early cortisol levels and adverse outcomes in infants receiving hydrocortisone.

Main Methods:

  • Secondary analysis of the multicenter randomized controlled PREMILOC trial.
  • Inclusion of inborn infants delivered before 28 weeks of gestation.
  • Development of sex-specific nomograms for baseline serum cortisol values in 325 neonates.
  • Analysis of BPD-free survival and severe adverse events using multivariate logistic regression based on cortisol z-scores.

Main Results:

  • Higher baseline cortisol levels were associated with increased BPD-free survival in placebo-treated infants (aOR 1.57 [1.08-2.27]).
  • In infants treated with prophylactic hydrocortisone, elevated cortisol z-scores predicted higher risks of severe intraventricular hemorrhage (aOR 1.82 [1.06-3.15]) and spontaneous intestinal perforation (aOR 4.81 [1.34-17.22]).
  • No predictive value of baseline cortisol for BPD-free survival was found in hydrocortisone-treated infants.

Conclusions:

  • Baseline serum cortisol levels do not predict BPD-free survival in extremely preterm infants treated with hydrocortisone.
  • High early postnatal cortisol levels in infants receiving hydrocortisone are linked to an increased risk of severe intraventricular hemorrhage and spontaneous intestinal perforation.
  • The findings suggest a potentially lower benefit/risk ratio for prophylactic hydrocortisone in extremely preterm infants with high early cortisol levels.
Abstract